Quick Answer
aTYR PHARMA INC reported Long-Term Debt of $8.26 million for fiscal year 2018.
aTYR PHARMA INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2018 | $8.26M | -43.9% |
| 2017 | $14.72M | +60.0% |
| 2016 | $9.20M | +417.9% |
| 2015 | $1.78M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2019 | $2.74M | -72.8% | -40.4% |
| June 30, 2019 | $4.60M | -61.2% | -28.6% |
| March 31, 2019 | $6.44M | -50.3% | -22.1% |
| December 31, 2018 | $8.26M | -43.9% | -17.9% |
| September 30, 2018 | $10.06M | -19.3% | -15.0% |
| June 30, 2018 | $11.85M | +0.5% | -8.5% |
| March 31, 2018 | $12.95M | +52.7% | -12.0% |
| December 31, 2017 | $14.72M | +60.0% | +18.0% |
- aTYR PHARMA INC showed a decrease of -43.9% in Long-Term Debt compared to the prior fiscal year.
- Over the 2015–2018 period, aTYR PHARMA INC’s long-term debt has grown by 365.3% (from $1.78 million to $8.26 million).
- The most recent figure is from aTYR PHARMA INC’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 26, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: